drugset / Trial / NCT01877564

A Randomized Pilot Study to Evaluate the Effects of a Short Course of Metformin Versus No Therapy in the Period Prior to Hysterectomy for Grade 1-2 Adenocarcinoma of the Endometrium in Obese Non-Diabetic Women

NCT01877564 ↗

Phase 2 Completed 10 enrolled University of Arkansas
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this research is to determine the effects of Metformin, a well tolerated drug widely prescribed for treatment of Type 2 Diabetes Mellitus, on endometrium cancer patients.

Timeline

Start
2013-08-29
Primary completion
2016-08-10
Completion
2017-07-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 500 mg Oral